Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2017

Open Access 01-12-2017 | Research Article

On the censored cost-effectiveness analysis using copula information

Authors: Charles Fontaine, Jean-Pierre Daurès, Paul Landais

Published in: BMC Medical Research Methodology | Issue 1/2017

Login to get access

Abstract

Background

Information and theory beyond copula concepts are essential to understand the dependence relationship between several marginal covariates distributions. In a therapeutic trial data scheme, most of the time, censoring occurs. That could lead to a biased interpretation of the dependence relationship between marginal distributions. Furthermore, it could result in a biased inference of the joint probability distribution function. A particular case is the cost-effectiveness analysis (CEA), which has shown its utility in many medico-economic studies and where censoring often occurs.

Methods

This paper discusses a copula-based modeling of the joint density and an estimation method of the costs, and quality adjusted life years (QALY) in a cost-effectiveness analysis in case of censoring. This method is not based on any linearity assumption on the inferred variables, but on a punctual estimation obtained from the marginal distributions together with their dependence link.

Results

Our results show that the proposed methodology keeps only the bias resulting statistical inference and don’t have anymore a bias based on a unverified linearity assumption. An acupuncture study for chronic headache in primary care was used to show the applicability of the method and the obtained ICER keeps in the confidence interval of the standard regression methodology.

Conclusion

For the cost-effectiveness literature, such a technique without any linearity assumption is a progress since it does not need the specification of a global linear regression model. Hence, the estimation of the a marginal distributions for each therapeutic arm, the concordance measures between these populations and the right copulas families is now sufficient to process to the whole CEA.
Literature
1.
go back to reference Willan A, Lin D. Incremental net benefit in randomized clinical trial. Stat Med. 2001; 20:1563–74.CrossRefPubMed Willan A, Lin D. Incremental net benefit in randomized clinical trial. Stat Med. 2001; 20:1563–74.CrossRefPubMed
2.
go back to reference Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53:457–81.CrossRef Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53:457–81.CrossRef
3.
go back to reference Zhao H, Bang H, Wang H, Pfeifer PE. On the equivalence of some medical cost estimators with censored data. Stat med. 2007; 26(24):4520–30.CrossRefPubMed Zhao H, Bang H, Wang H, Pfeifer PE. On the equivalence of some medical cost estimators with censored data. Stat med. 2007; 26(24):4520–30.CrossRefPubMed
4.
go back to reference Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. New England J Med. 1977; 296(13):716–21.CrossRef Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. New England J Med. 1977; 296(13):716–21.CrossRef
5.
go back to reference Willan A, Chen E, Cook R, Lin D. Incremental net benefit in clinical trials with quality-adjusted survival. Stat Med. 2003; 22:353–62.CrossRefPubMed Willan A, Chen E, Cook R, Lin D. Incremental net benefit in clinical trials with quality-adjusted survival. Stat Med. 2003; 22:353–62.CrossRefPubMed
6.
go back to reference Willan A, Lin D, Manca A. Regression methods for cost-effectiveness analysis with censored data. Stat Med. 2005; 24:131–45.CrossRefPubMed Willan A, Lin D, Manca A. Regression methods for cost-effectiveness analysis with censored data. Stat Med. 2005; 24:131–45.CrossRefPubMed
7.
go back to reference Pullenayegum E, Willan A. Semi-parametric regression models for cost-effectiveness analysis: Improving the efficiency of estimation from censored data. Stat Med. 2007; 26:3274–99.CrossRefPubMed Pullenayegum E, Willan A. Semi-parametric regression models for cost-effectiveness analysis: Improving the efficiency of estimation from censored data. Stat Med. 2007; 26:3274–99.CrossRefPubMed
8.
go back to reference Sklar M. Fonctions de répartition à n dimensions et leurs marges. Publ Inst Statist Univ Paris. 1959; 8:229–31. Sklar M. Fonctions de répartition à n dimensions et leurs marges. Publ Inst Statist Univ Paris. 1959; 8:229–31.
9.
go back to reference Embrechts P, McNeil A, Straumann D. Correlation and dependence in risk management: properties and pitfalls. Risk management: value at risk and beyond. 2002;:176–223. Embrechts P, McNeil A, Straumann D. Correlation and dependence in risk management: properties and pitfalls. Risk management: value at risk and beyond. 2002;:176–223.
10.
go back to reference Frees EW, Valdez EA. Understanding relationships using copulas. North Am Actuar J. 1998; 2(1):1–25.CrossRef Frees EW, Valdez EA. Understanding relationships using copulas. North Am Actuar J. 1998; 2(1):1–25.CrossRef
11.
go back to reference Hougaard P. Analysis of multivariate survival data: Springer Science & Business Media; 2012. Hougaard P. Analysis of multivariate survival data: Springer Science & Business Media; 2012.
12.
go back to reference Nelsen RB. An introduction to copulas. Springer Series in Statistics. New York: Springer; 2006. Nelsen RB. An introduction to copulas. Springer Series in Statistics. New York: Springer; 2006.
13.
go back to reference Thompson S, Nixon R. How sensitive are cost-effectiveness analyses to choice of parametric distributions?Med Decision Making. 2007; 4:416–23. Thompson S, Nixon R. How sensitive are cost-effectiveness analyses to choice of parametric distributions?Med Decision Making. 2007; 4:416–23.
14.
go back to reference Stamey J, Beavers D, Faries D, Price K, Seaman J. Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study. Pharm Stat. 2014; 13:94–100.CrossRefPubMed Stamey J, Beavers D, Faries D, Price K, Seaman J. Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study. Pharm Stat. 2014; 13:94–100.CrossRefPubMed
15.
16.
go back to reference Buckley J, James I. Linear regression with censored data. Biometrika. 1979; 66:429–36.CrossRef Buckley J, James I. Linear regression with censored data. Biometrika. 1979; 66:429–36.CrossRef
17.
go back to reference Miller R, Halpern J. Regression with censored data. Biometrika. 1982; 69-3:521–31.CrossRef Miller R, Halpern J. Regression with censored data. Biometrika. 1982; 69-3:521–31.CrossRef
18.
go back to reference Genest C, Rivest LP. Statistical inference procedures for bivariate archimedean copulas. J Am Stat Assoc. 1993; 88:1034–43.CrossRef Genest C, Rivest LP. Statistical inference procedures for bivariate archimedean copulas. J Am Stat Assoc. 1993; 88:1034–43.CrossRef
19.
go back to reference Genest C, Ghoudi K, Rivest LP. A semiparametric estimation procedure of dependence parameters in multivariate families of distributions. Biometrika. 1995; 82:543–52.CrossRef Genest C, Ghoudi K, Rivest LP. A semiparametric estimation procedure of dependence parameters in multivariate families of distributions. Biometrika. 1995; 82:543–52.CrossRef
20.
go back to reference Brahimi B, Necir A. A semiparametric estimation of copula models based on the method of moments. Stat Method. 2012; 9(4):467–77.CrossRef Brahimi B, Necir A. A semiparametric estimation of copula models based on the method of moments. Stat Method. 2012; 9(4):467–77.CrossRef
21.
22.
go back to reference Oakes D. A concordance test for independence in the presence of censoring. Biometrics. 1982; 38:451–5.CrossRefPubMed Oakes D. A concordance test for independence in the presence of censoring. Biometrics. 1982; 38:451–5.CrossRefPubMed
23.
go back to reference Oakes D. On consistency of kendall’s tau under censoring. Biometrika. 2008; 95-4:997–1001.CrossRef Oakes D. On consistency of kendall’s tau under censoring. Biometrika. 2008; 95-4:997–1001.CrossRef
24.
go back to reference Lakhal-Chaieb L. Copula inference under censoring. Biometrika. 2010; 97-2:505–12.CrossRef Lakhal-Chaieb L. Copula inference under censoring. Biometrika. 2010; 97-2:505–12.CrossRef
25.
go back to reference Dos Santos Silva R, Freitas Lopes H. Copula, marginal distributions and model selection: a bayesian note. Stat Comput. 2008; 18:313–20.CrossRef Dos Santos Silva R, Freitas Lopes H. Copula, marginal distributions and model selection: a bayesian note. Stat Comput. 2008; 18:313–20.CrossRef
26.
go back to reference Genest C, Neslehova J, Ben Ghorbal N. Estimators based on kendall’s tau in multivariate copula models. Aust NZ J Stat. 2011; 53:157–77.CrossRef Genest C, Neslehova J, Ben Ghorbal N. Estimators based on kendall’s tau in multivariate copula models. Aust NZ J Stat. 2011; 53:157–77.CrossRef
27.
go back to reference El Maache H, Lepage Y. Spearman’s rho and kendall’s tau for multivariate data sets. Math Stat Appl, Lect Notes-Monograph Series. 2003; 42:113–30. El Maache H, Lepage Y. Spearman’s rho and kendall’s tau for multivariate data sets. Math Stat Appl, Lect Notes-Monograph Series. 2003; 42:113–30.
28.
go back to reference Fieller EC. Some problems in interval estimation. J Stat Royal Soc Ser B. 1954; 16:175–85. Fieller EC. Some problems in interval estimation. J Stat Royal Soc Ser B. 1954; 16:175–85.
29.
go back to reference Willan A, O’Brien B. Confidence intervals for cost-effectiveness ratios: an application of fieller’s theorem. Health Econ. 1996; 5:297–305.CrossRefPubMed Willan A, O’Brien B. Confidence intervals for cost-effectiveness ratios: an application of fieller’s theorem. Health Econ. 1996; 5:297–305.CrossRefPubMed
30.
go back to reference Chaudhary N, Stearns S. Confidence intervals for cost-effectiveness ratios: an example from randomized trial. Stat Med. 1996; 15:1447–58.CrossRefPubMed Chaudhary N, Stearns S. Confidence intervals for cost-effectiveness ratios: an example from randomized trial. Stat Med. 1996; 15:1447–58.CrossRefPubMed
31.
go back to reference Siani C, Moatti JP. Quelles méthodes de calcul des régions de confiance du ratio coût-efficacité incrémental choisir?: Universites d’Aix-Marseille II et III; 2002. Siani C, Moatti JP. Quelles méthodes de calcul des régions de confiance du ratio coût-efficacité incrémental choisir?: Universites d’Aix-Marseille II et III; 2002.
32.
go back to reference Bang H, Zhao H. Median-based incremental cost-effectiveness ratio (icer). J Stat Theory Prac. 2012; 6(3):428–42.CrossRef Bang H, Zhao H. Median-based incremental cost-effectiveness ratio (icer). J Stat Theory Prac. 2012; 6(3):428–42.CrossRef
33.
go back to reference Nixon R, Thompson S. Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. Health Econ. 2005; 14:1217–29.CrossRefPubMed Nixon R, Thompson S. Methods for incorporating covariate adjustment, subgroup analysis and between-centre differences into cost-effectiveness evaluations. Health Econ. 2005; 14:1217–29.CrossRefPubMed
34.
go back to reference Tsai K-T, Peace KE, et al. Analysis of subgroup data in clinical trials. Journal of Causal Inference. 2013; 1(2):193–207. De Gruyter.CrossRef Tsai K-T, Peace KE, et al. Analysis of subgroup data in clinical trials. Journal of Causal Inference. 2013; 1(2):193–207. De Gruyter.CrossRef
35.
go back to reference Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith CM, Ellis N, et al.Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial. Bmj. 2004; 328(7442):744.CrossRefPubMedPubMedCentral Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith CM, Ellis N, et al.Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial. Bmj. 2004; 328(7442):744.CrossRefPubMedPubMedCentral
36.
go back to reference Wonderling D, Vickers A, Grieve R, McCarney R. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. British Med J. 2004; 328:747–9.CrossRef Wonderling D, Vickers A, Grieve R, McCarney R. Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. British Med J. 2004; 328:747–9.CrossRef
38.
go back to reference Kojadinovic I, Yan J, et al.Modeling multivariate distributions with continuous margins using the copula r package. J Stat Softw. 2010; 34(9):1–20.CrossRef Kojadinovic I, Yan J, et al.Modeling multivariate distributions with continuous margins using the copula r package. J Stat Softw. 2010; 34(9):1–20.CrossRef
39.
go back to reference Brechmann E, Schepsmeier U. Modeling dependence with c-and d-vine copulas: The r-package cdvine. J Stat Softw. 2013; 52(3):1–27.CrossRef Brechmann E, Schepsmeier U. Modeling dependence with c-and d-vine copulas: The r-package cdvine. J Stat Softw. 2013; 52(3):1–27.CrossRef
Metadata
Title
On the censored cost-effectiveness analysis using copula information
Authors
Charles Fontaine
Jean-Pierre Daurès
Paul Landais
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2017
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/s12874-017-0305-9

Other articles of this Issue 1/2017

BMC Medical Research Methodology 1/2017 Go to the issue